GPT and cancer: The hypothesis that TERRA can antagonize telomerase-dependent telomere maintenance along with the observation that telomerase-positive tumor cells have decreased TERRA levels compared to ALT-positive cancer cells [46], suggests that TERRA may have clinical relevance and could represent a novel target for the development of specific anticancer therapeutic interventions.